Cryoablation Challenge Evaluated in Adaptive-Immune Resistance (CEDAR)
MD Anderson Study Status
This interventional trial studies the effectiveness of adding cryoablation treatment in patients who are receiving standard of care immunotherapy to treat cancer that is has spread to other parts of the body (metastatic). Cryoablation uses a probe that freezes the tissue around the tumor to try to kill the cancer cells. Using cryoablation to treat cancerous lesions may help to kill the cancer cells.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Metastatic Malignant Neoplasm
For general questions about clinical trials: